Methyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate

Catalog No. :
ACLKVC213
CAS No. :
2787516-03-2
Molecular Formula :
C20H32BFO6Si
Molecular Weight :
426.37

IUPAC Name:methyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate

Methyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate
IUPAC Namemethyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate
Molecular FormulaC20H32BFO6Si
Molecular Weight426.37
SMILESO=C(OC)C1=CC(B2OC(C)(C)C(C)(C)O2)=C(F)C=C1OCOCC[Si](C)(C)C
InChI KeyUXAMCLSJJHHOEZ-UHFFFAOYSA-N
SynonymBenzoic acid, 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[[2-(trimethylsilyl)ethoxy]methoxy]-, methyl ester;Methyl 4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-((2-(trimethylsilyl)ethoxy)methoxy)benzoate
CAS No.2787516-03-2

Synthetic Route by SureRoute

1. ACLKVC213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKVC213 route product structure diagram
    ACLKVC2132787516-03-2
Inquiry

2. ACLKVC213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKVC213 route product structure diagram
    ACLKVC2132787516-03-2
Inquiry

Comments (0)